| Product Code: ETC9517810 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Suriname Oncology-Cancer Drugs Market Overview |
3.1 Suriname Country Macro Economic Indicators |
3.2 Suriname Oncology-Cancer Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Suriname Oncology-Cancer Drugs Market - Industry Life Cycle |
3.4 Suriname Oncology-Cancer Drugs Market - Porter's Five Forces |
3.5 Suriname Oncology-Cancer Drugs Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Suriname Oncology-Cancer Drugs Market Revenues & Volume Share, By Indication, 2021 & 2031F |
4 Suriname Oncology-Cancer Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Suriname |
4.2.2 Growing awareness about the benefits of oncology-cancer drugs |
4.2.3 Technological advancements leading to the development of more effective drugs |
4.3 Market Restraints |
4.3.1 High cost of oncology-cancer drugs |
4.3.2 Limited access to advanced cancer treatment facilities in Suriname |
4.3.3 Stringent regulations and approval processes for new drugs |
5 Suriname Oncology-Cancer Drugs Market Trends |
6 Suriname Oncology-Cancer Drugs Market, By Types |
6.1 Suriname Oncology-Cancer Drugs Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Suriname Oncology-Cancer Drugs Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Suriname Oncology-Cancer Drugs Market Revenues & Volume, By Chemotherapy, 2021- 2031F |
6.1.4 Suriname Oncology-Cancer Drugs Market Revenues & Volume, By Targeted Therapy, 2021- 2031F |
6.1.5 Suriname Oncology-Cancer Drugs Market Revenues & Volume, By Immunotherapy (Biologic Therapy), 2021- 2031F |
6.1.6 Suriname Oncology-Cancer Drugs Market Revenues & Volume, By Hormonal Therapy, 2021- 2031F |
6.2 Suriname Oncology-Cancer Drugs Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 Suriname Oncology-Cancer Drugs Market Revenues & Volume, By Lung Cancer, 2021- 2031F |
6.2.3 Suriname Oncology-Cancer Drugs Market Revenues & Volume, By Stomach Cancer, 2021- 2031F |
6.2.4 Suriname Oncology-Cancer Drugs Market Revenues & Volume, By Colorectal Cancer, 2021- 2031F |
6.2.5 Suriname Oncology-Cancer Drugs Market Revenues & Volume, By Breast Cancer, 2021- 2031F |
6.2.6 Suriname Oncology-Cancer Drugs Market Revenues & Volume, By Prostate Cancer, 2021- 2031F |
6.2.7 Suriname Oncology-Cancer Drugs Market Revenues & Volume, By Liver Cancer, 2021- 2031F |
6.2.8 Suriname Oncology-Cancer Drugs Market Revenues & Volume, By Other Cancers, 2021- 2031F |
6.2.9 Suriname Oncology-Cancer Drugs Market Revenues & Volume, By Other Cancers, 2021- 2031F |
7 Suriname Oncology-Cancer Drugs Market Import-Export Trade Statistics |
7.1 Suriname Oncology-Cancer Drugs Market Export to Major Countries |
7.2 Suriname Oncology-Cancer Drugs Market Imports from Major Countries |
8 Suriname Oncology-Cancer Drugs Market Key Performance Indicators |
8.1 Patient survival rates post-treatment |
8.2 Rate of adoption of new oncology-cancer drugs in Suriname |
8.3 Number of clinical trials conducted for oncology drugs in the country |
9 Suriname Oncology-Cancer Drugs Market - Opportunity Assessment |
9.1 Suriname Oncology-Cancer Drugs Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Suriname Oncology-Cancer Drugs Market Opportunity Assessment, By Indication, 2021 & 2031F |
10 Suriname Oncology-Cancer Drugs Market - Competitive Landscape |
10.1 Suriname Oncology-Cancer Drugs Market Revenue Share, By Companies, 2024 |
10.2 Suriname Oncology-Cancer Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here